A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice

Multiple Myeloma (MM) often present with unspecific symptoms, which can lead to diagnostic delay. Serum-free light chain (sFLC) ratio is suggested to replace urine protein electrophoresis (UPE) in the diagnostic work-up of myeloma. We aimed to investigate the performance of the sFLC-ratio in general...

Full description

Bibliographic Details
Main Authors: Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Mie Hessellund Samson, Holger Jon Møller
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/12/2930
_version_ 1797489105648484352
author Birgitte Sandfeld-Paulsen
Ninna Aggerholm-Pedersen
Mie Hessellund Samson
Holger Jon Møller
author_facet Birgitte Sandfeld-Paulsen
Ninna Aggerholm-Pedersen
Mie Hessellund Samson
Holger Jon Møller
author_sort Birgitte Sandfeld-Paulsen
collection DOAJ
description Multiple Myeloma (MM) often present with unspecific symptoms, which can lead to diagnostic delay. Serum-free light chain (sFLC) ratio is suggested to replace urine protein electrophoresis (UPE) in the diagnostic work-up of myeloma. We aimed to investigate the performance of the sFLC-ratio in general practice (GP) compared to UPE, just as we explored different sFLC-ratio cut-offs’ influence on diagnostic values. In a cohort of 13,210 patients from GP measures of sFLC-ratio, serum protein electrophoresis (SPE), or UPE were compared to diagnoses of incident M-component related diseases acquired from Danish health registers. UPE and sFLC-ratio equally improved diagnostic values when combined with SPE (sensitivity: SPE and UPE: 95.6 (90.6–98.4); SPE and sFLC-ratio: 95.1 (90.2–98.0)). The addition of the sFLC-ratio to SPE resulted in the identification of 13 patients with MGUS, light chain disease and amyloidosis, which was in line with the addition of UPE to SPE. The number of false-positive tests was UPE and SPE: 364 (11%) and sFLC-ratio and SPE: 677(19%). Expanding sFLC-ratio reference range to 0.26–4.32 resulted in a significant reduction in false positives <i>n</i> = 226 (6%) without loss of patients with clinical plasma cell dyscrasias. sFLC-ratio improves the diagnostic value of SPE in GP. However, due to low specificity and a large number of false positives, expanded cut-off values should be considered.
first_indexed 2024-03-10T00:12:44Z
format Article
id doaj.art-16da9835a80c40eb9521451c90811263
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T00:12:44Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-16da9835a80c40eb9521451c908112632023-11-23T15:56:40ZengMDPI AGCancers2072-66942022-06-011412293010.3390/cancers14122930A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General PracticeBirgitte Sandfeld-Paulsen0Ninna Aggerholm-Pedersen1Mie Hessellund Samson2Holger Jon Møller3Department of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, DenmarkDepartment of Oncology, Aarhus University Hospital, 8200 Aarhus, DenmarkDepartment of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, DenmarkDepartment of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, DenmarkMultiple Myeloma (MM) often present with unspecific symptoms, which can lead to diagnostic delay. Serum-free light chain (sFLC) ratio is suggested to replace urine protein electrophoresis (UPE) in the diagnostic work-up of myeloma. We aimed to investigate the performance of the sFLC-ratio in general practice (GP) compared to UPE, just as we explored different sFLC-ratio cut-offs’ influence on diagnostic values. In a cohort of 13,210 patients from GP measures of sFLC-ratio, serum protein electrophoresis (SPE), or UPE were compared to diagnoses of incident M-component related diseases acquired from Danish health registers. UPE and sFLC-ratio equally improved diagnostic values when combined with SPE (sensitivity: SPE and UPE: 95.6 (90.6–98.4); SPE and sFLC-ratio: 95.1 (90.2–98.0)). The addition of the sFLC-ratio to SPE resulted in the identification of 13 patients with MGUS, light chain disease and amyloidosis, which was in line with the addition of UPE to SPE. The number of false-positive tests was UPE and SPE: 364 (11%) and sFLC-ratio and SPE: 677(19%). Expanding sFLC-ratio reference range to 0.26–4.32 resulted in a significant reduction in false positives <i>n</i> = 226 (6%) without loss of patients with clinical plasma cell dyscrasias. sFLC-ratio improves the diagnostic value of SPE in GP. However, due to low specificity and a large number of false positives, expanded cut-off values should be considered.https://www.mdpi.com/2072-6694/14/12/2930serum-free light chain (sFLC) ratioMultiple Myelomageneral practicediagnostic work-up
spellingShingle Birgitte Sandfeld-Paulsen
Ninna Aggerholm-Pedersen
Mie Hessellund Samson
Holger Jon Møller
A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
Cancers
serum-free light chain (sFLC) ratio
Multiple Myeloma
general practice
diagnostic work-up
title A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
title_full A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
title_fullStr A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
title_full_unstemmed A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
title_short A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
title_sort cohort study of free light chain ratio in combination with serum protein electrophoresis as a first line test in general practice
topic serum-free light chain (sFLC) ratio
Multiple Myeloma
general practice
diagnostic work-up
url https://www.mdpi.com/2072-6694/14/12/2930
work_keys_str_mv AT birgittesandfeldpaulsen acohortstudyoffreelightchainratioincombinationwithserumproteinelectrophoresisasafirstlinetestingeneralpractice
AT ninnaaggerholmpedersen acohortstudyoffreelightchainratioincombinationwithserumproteinelectrophoresisasafirstlinetestingeneralpractice
AT miehessellundsamson acohortstudyoffreelightchainratioincombinationwithserumproteinelectrophoresisasafirstlinetestingeneralpractice
AT holgerjonmøller acohortstudyoffreelightchainratioincombinationwithserumproteinelectrophoresisasafirstlinetestingeneralpractice
AT birgittesandfeldpaulsen cohortstudyoffreelightchainratioincombinationwithserumproteinelectrophoresisasafirstlinetestingeneralpractice
AT ninnaaggerholmpedersen cohortstudyoffreelightchainratioincombinationwithserumproteinelectrophoresisasafirstlinetestingeneralpractice
AT miehessellundsamson cohortstudyoffreelightchainratioincombinationwithserumproteinelectrophoresisasafirstlinetestingeneralpractice
AT holgerjonmøller cohortstudyoffreelightchainratioincombinationwithserumproteinelectrophoresisasafirstlinetestingeneralpractice